E-LIB Suche - Ergebnisse für: Daffinà, Maria Grazia

1

474 A case of Takotsubo cardiomyopathy in SARS-CoV-2 infect..:

Bava, Annita ; Daffinà, Maria Grazia ; Cama, Giuseppe...
European Heart Journal Supplements. 23 (2021) Supplement_G - p. , 2021

Link: https://doi.org/10.1093/..

2

Circulating Levels of PD-L1 in Mesothelioma Patients from t..:

Chiarucci, Carla ; Cannito, Sara ; Daffinà, Maria Grazia...
Cancers. 12 (2020) 2 - p. 361 , 2020

Link: https://doi.org/10.3390/..

3

Osimertinib in the treatment of non-small-cell lung cancer:..:

Santarpia, Mariacarmela ; Liguori, Alessia ; Karachaliou, Niki...
Lung Cancer: Targets and Therapy. 8 (2017) - p. 109-125 , 2017

Link: https://doi.org/10.2147/..

4

Spotlight on ceritinib in the treatment of ALK+ NSCLC: desi..:

Santarpia, Mariacarmela ; Daffinà, Maria Grazia ; D'Aveni, Alessandro...
Drug Design, Development and Therapy. 11 (2017) - p. 2047-2063 , 2017

Link: https://doi.org/10.2147/..

5

PREDICTIVE BIOMARKER OF LONG TERM SURVIVAL IN MESOTHELIOMA ..:

Daffinà, Maria Grazia
http://hdl.handle.net/11365/1160848. , 2021

Link: http://hdl.handle.net/11..

6

Circulating Levels of PD-L1 in Mesothelioma Patients from t..:

Chiarucci, Carla ; Cannito, Sara ; Daffinà, Maria Grazia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072596/. , 2020

Link: http://www.ncbi.nlm.nih...

7

Liquid biopsy for lung cancer early detection:

Santarpia, Mariacarmela ; Liguori, Alessia ; D'Aveni, Alessandro...
info:eu-repo/semantics/altIdentifier/pmid/29780635. , 2018

Link: http://hdl.handle.net/11..

8

Osimertinib in the treatment of non-small-cell lung cancer:..:

Santarpia, Mariacarmela ; Liguori, Alessia ; Karachaliou, Niki...
info:eu-repo/semantics/altIdentifier/doi/10.2147/LCTT.S119644. , 2017

Link: https://www.dovepress.co..

9

Osimertinib in the treatment of non-small-cell lung cancer:..:

Santarpia, Mariacarmela ; Liguori, Alessia ; Karachaliou, Niki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571822/. , 2017

Link: http://www.ncbi.nlm.nih...

10

Spotlight on ceritinib in the treatment of ALK+ NSCLC:Desig..:

Santarpia, Mariacarmela ; Daffinà, Maria Grazia ; D'Aveni, Alessandro...
Santarpia , M , Daffinà , M G , D'Aveni , A , Marabello , G , Liguori , A , Giovannetti , E , Karachaliou , N , Cao , M G , Rosell , R & Altavilla , G 2017 , ' Spotlight on ceritinib in the treatment of ALK+ NSCLC : Design, development and place in therapy ' , Drug Design, Development and Therapy , vol. 11 , pp. 2047-2063 . https://doi.org/10.2147/DDDT.S113500. , 2017

Link: https://research.vumc.nl..

11

Osimertinib in the treatment of non-small-cell lung cancer:..:

Santarpia, Mariacarmela ; Liguori, Alessia ; Karachaliou, Niki...
info:eu-repo/semantics/altIdentifier/pmid/28860885. , 2017

Link: http://hdl.handle.net/11..

12

Spotlight on ceritinib in the treatment of ALK+ NSCLC: desi..:

SANTARPIA, Mariacarmela ; DAFFINA', MARIA GRAZIA ; D'AVENI, ALESSANDRO...
info:eu-repo/semantics/altIdentifier/pmid/28740365. , 2017

Link: http://hdl.handle.net/11..

13

Spotlight on ceritinib in the treatment of ALK+ NSCLC: desi..:

Santarpia, Mariacarmela ; DaffinÃ, Maria Grazia ; D'Aveni, Alessandro...
info:eu-repo/semantics/altIdentifier/doi/10.2147/DDDT.S113500. , 2017

Link: https://www.dovepress.co..

14

Spotlight on ceritinib in the treatment of ALK+ NSCLC: desi..:

Santarpia, Mariacarmela ; Daffinà, Maria Grazia ; D'Aveni, Alessandro...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503498/. , 2017

Link: http://www.ncbi.nlm.nih...

15

Targeted drugs in small-cell lung cancer:

SANTARPIA, Mariacarmela ; DAFFINA', MARIA GRAZIA ; Karachaliou, Niki...
info:eu-repo/semantics/altIdentifier/pmid/26958493. , 2016

Link: http://hdl.handle.net/11..